These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2138211)

  • 1. Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus.
    Tan CH; Yap EH; Singh M; Deubel V; Chan YC
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():745-9. PubMed ID: 2138211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1.
    Falconar AK; Young PR
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():961-5. PubMed ID: 1849979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.
    Falgout B; Bray M; Schlesinger JJ; Lai CJ
    J Virol; 1990 Sep; 64(9):4356-63. PubMed ID: 2143542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
    Henchal EA; Henchal LS; Schlesinger JJ
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2101-7. PubMed ID: 3404125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model.
    Amorim JH; dos Santos Alves RP; Bizerra R; Araújo Pereira S; Ramos Pereira L; Nascimento Fabris DL; Santos RA; Romano CM; de Souza Ferreira LC
    Virology; 2016 Jan; 487():41-9. PubMed ID: 26496698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody.
    Tian Y; Chen W; Yang Y; Xu X; Zhang J; Wang J; Xiao L; Chen Z
    Appl Microbiol Biotechnol; 2013 Feb; 97(4):1553-60. PubMed ID: 23081772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a monoclonal antibody against non-structural protein 3 of dengue-2 virus by intrasplenic injection.
    Chen Z; Tian Y; Liu L; An J
    Hybridoma (Larchmt); 2008 Dec; 27(6):467-71. PubMed ID: 19108619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus.
    Costa SM; Freire MS; Alves AM
    Vaccine; 2006 May; 24(21):4562-4. PubMed ID: 16140430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design.
    Falconar AK
    Clin Vaccine Immunol; 2007 May; 14(5):493-504. PubMed ID: 17329445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
    Putnak JR; Schlesinger JJ
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
    Kaufman BM; Summers PL; Dubois DR; Cohen WH; Gentry MK; Timchak RL; Burke DS; Eckels KH
    Am J Trop Med Hyg; 1989 Nov; 41(5):576-80. PubMed ID: 2817214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
    Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of a monoclonal antibody specific for NS3 protease and the ATPase region of Dengue-2 virus.
    García-Cordero J; Ramirez HR; Vazquez-Ochoa M; Gutierrez-Castañeda B; Santos-Argumedo L; Villegas-Sepúlveda N; Cedillo-Barrón L
    Hybridoma (Larchmt); 2005 Jun; 24(3):160-4. PubMed ID: 15943564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.
    Lazo L; Hermida L; Zulueta A; Sánchez J; López C; Silva R; Guillén G; Guzmán MG
    Vaccine; 2007 Jan; 25(6):1064-70. PubMed ID: 17097199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of anti-dengue NS1 antibody by western blot.
    Kuno G; Vorndam AV; Gubler DJ; Gómez I
    J Med Virol; 1990 Oct; 32(2):102-8. PubMed ID: 2149144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli.
    Mason PW; Zügel MU; Semproni AR; Fournier MJ; Mason TL
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2107-14. PubMed ID: 1698924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice.
    Izquierdo A; García A; Lazo L; Gil L; Marcos E; Alvarez M; Valdés I; Hermida L; Guillén G; Guzmán MG
    Arch Virol; 2014 Oct; 159(10):2597-604. PubMed ID: 24841761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.